Speakers

Lowell Anthony, Ranjana Arora, Firas Badin, Therese Bocklage, Michael Cavnar, Aman Chauhan, Holly Chitwood, Justine Cooper, Daniel Flora, Gerhard Hildebrandt, Jacob Hodskins, Joseph Kim, Charles Kunos, Amber Lawson, Rachel Miller, Rachael Morgan, Brooke Phillips, Reshma Ramlal, Hayder Saeed, Eytan Stein, Rachel Stewart, John Villano, Peng Wang, Shulin Zhang

Lowell Anthony, MD, FACP

Professor
Medicine and Medical Oncology
University of Kentucky
College of Medicine
UK HealthCare
Lexington, Kentucky

Dr. Lowell Anthony is medical oncologist with a focus on gastrointestinal and neuroendocrine neoplasms and supportive care. He is a Professor of Medicine and Chief of the Division of Medical Oncology and on the staff of the Markey Cancer Center. Dr. Anthony received his undergraduate degree from King College, Bristol, Tennessee and his medical and postgraduate training in medical oncology and clinical pharmacology at Vanderbilt University Medical Center in Nashville, TN. Dr. Anthony is board certified in Internal Medicine and Medical Oncology. Prior to joining the University of Kentucky, he was a Professor of Medicine at LSUHSC in New Orleans.

A fellow of the American College of Physicians, Dr. Anthony is an active member of several professional organizations. He served on Committees with the American Society of Clinical Oncology and the American Society of Clinical Pharmacology and Therapeutics, and he is a member of the American Association for Cancer Research and the American Federation of Medical Research. He is also a member of the Southern Society for Clinical Investigation, a founding member and on the board of directors of the North American Neuroendocrine Tumor Society (NANETS) for 5 years. Dr. Anthony is also listed among the “Best Doctors” in the U.S. for the last 6 years.

Dr Anthony has served as Chairman of the Cancer Committee for the Medical Center of Louisiana Hospital Cancer Program, the Advisory Board for the General Clinical Research Center, member of the Chandler Medical Center’s cancer committee, Co-chair of he Markey Cancer Center’s Protocol and Review Committee. His work has appeared in the Journal of Clinical Oncology, the Italian Journal of Gastroenterology, Cancer Research, Clinical Pharmacology Therapeutics, the British Journal of Clinical Pharmacology, the American Journal of Surgery, the Journal of Nuclear Medicine and the Annals of Internal Medicine. He has written and co-authored many book chapters, abstracts, and audiovisual media. He is a reviewer for the Journal of Nuclear Medicine, the New England Journal of Medicine, Annals of Internal Medicine, the Journal of Clinical Oncology and Cancer among other publications. He has been a guest lecturer at numerous national and international scientific forums.

Back to top

Ranjana Arora, MD, MPH, FCAP

Assistant Professor of Pathology and Laboratory Medicine
Medical Director
Molecular Hematology Services
University of Kentucky
Lexington, Kentucky

Back to top

Firas Badin, MD

Physician
BHMG Hematology and Oncology
Lexington, Kentucky

Dr. Firas Benyamine Badin, MD is a medical oncologist at Baptist Health in Lexington, KY. Dr. Badin earned his medical degree from University of Damascus Medical School in Syria. He completed his residency at Beth Israel Medical Center in New Jersey and his fellowship in hematology/oncology at the University of Kentucky. He is board certified in internal medicine, hematology and medical oncology. He is currently licensed to practice medicine in Kentucky. Dr. Badin treats patients with a variety of types of cancer. He serves as the principal investigator on several clinical trials.

Back to top

Therese Bocklage, MD

Professor of Pathology and Laboratory Medicine
University of Kentucky
College of Medicine
Lexington, Kentucky

Back to top

Michael Cavnar, MD

Assistant Professor of Surgery
Surgical Oncology
University of Kentucky
Markey Cancer Center
Lexington, Kentucky

Michael J. Cavnar, MD, is part of the surgical oncology and general surgery team at the UK Markey Cancer Center.

Cavnar earned his medical degree from the Columbia University Vagelos College of Physicians and Surgeons in New York. Afterward, he completed five years of a general surgery residency at New York University School of Medicine. He then completed a two-year fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City, the same institution where he spent the previous three years completing laboratory research under the guidance of Dr. Ronald DeMatteo through the Surgical Oncology Research Training Program. After the conclusion of 14 years of rigorous medical and surgical training in New York City, Cavnar was recruited to UK to join the Section of Surgical Oncology at the Markey Cancer Center.

Cavnar’s interests include treating cancers of the liver, biliary tract, pancreas, stomach and small intestine, as well as abdominal sarcomas. His clinical research during his fellowship at MSKCC focused on gastrointestinal stromal tumors (GIST), which is the most common type of sarcoma, and can occur throughout the GI tract.

Overall, with the expertise he gained through his training, Cavnar hopes to provide care and treatment to patients at UK HealthCare with a broad array of complex oncologic problems.

Back to top

Aman Chauhan, MD

Assistant Professor of Medicine
University of Kentucky
College of Medicine
Lexington, Kentucky

Aman Chauhan, MD, earned his medical degree from the Kasturba Medical College in Manipal, Karnataka, India. He completed a dual residency in internal medicine and pediatrics at Louisiana State University in New Orleans. Dr. Chauhan also completed a fellowship in hematology and oncology at UK with neuroendocrine tumor (NET) training led by Lowell Anthony,MD, and a Cancer Therapy Evaluation Program physician externship at the National Cancer institute that focused on designing clinical trials and clinical research projects. His clinical interests include treating carcinoid tumors, high-grade neuroendocrine carcinomas, and small and non-small cell lung cancer. As Markey’s director of NET theranostics, Dr. Chauhan identifies NET patients who qualify for Lutathera® (Lutetium 177 DOTATATE) treatments for gastroenteropancreatic neuroendocrine tumors (GEPNETs). Dr. Chauhan is board certified in internal medicine and specializes in the treatment of neuroendocrine tumors. He is a member of the medical oncology team at the UK Markey Cancer Center dedicated to multidisciplinary evaluation and treatment.

Back to top

Holly Chitwood, MSN, DNPc, APRN, FNP-B

Clinical Instructor of Pediatrics
University of Kentucky College of Medicine
Lexington, Kentucky

Holly Chitwood is an advanced nurse practitioner at the Medical Oncology Program of Markey Cancer Center. She began her career as a staff nurse in the field of Pediatric Hematology/Oncology with Kentucky Children's Hospital in 2006. She earned a bachelor's of science in social work from the University of the Cumberlands in 2001. She completed an associate degree in nursing at Eastern Kentucky University in 2006 and a bachelor's degree in nursing from Eastern Kentucky University in 2014. She completed a master's degree in nursing in 2015 at Lincoln Memorial University. Chitwood is a board certified family nurse practitioner and has completed the post masters Acute Care ( ACNP) program at university and is enrolled in DNP and then as Post–Masters Degree Acute Care Nurse Practitioner UK CON and DNP.

Back to top

Justine Cooper, MS, CGC

Genetic Counselor Supervisor
Markey Cancer Center
University of Kentucky
Lexington, Kentucky

Justine Pickarski is a Licensed Genetic Counselor at the University of Kentucky’s Markey Cancer Center. Justine obtained her Bachelor of Arts degree from Miami University in Oxford, Ohio and her Master of Science degree in Genetic Counseling from the University of Texas Health Science Center in Houston, Texas. She completed the Cancer Prevention Research Training Program (CPRTP) at MD Anderson in 2010. Justine is a genetic counselor supervisor and is responsible for providing programmatic leadership for genetic counseling services at Markey Cancer Center and also provides telegenetic counseling services for the Markey Cancer Center Affiliate Network. She is board certified by the American Board of Genetic Counseling.

Back to top

Daniel Flora, MD

Director
Oncology Research Program
St. Elizabeth Healthcare
Edgewood, Kentucky

Dr Daniel Flora received a Doctor of Pharmacy degree from University of Cincinnati before pursuing a medical degree from Wright State Boonshoft School of Medicine. Dr Flora completed residency and fellowship at University of Cincinnati. He is board certified in internal medicine, hematology and medical oncology. Dr Flora serves as medical director of the oncology research program at St Elizabeth Healthcare in Northern Kentucky.

Back to top

Gerhard Hildebrandt, MD

Professor, Medicine
University of Kentucky College of Medicine
Division Chief, Hematology and Blood & Marrow Transplantation
UK HealthCare
Lexington, Kentucky

Dr. Hildebrandt earned a medical degree from the Johannes Gutenberg University of Mainz Medical School, Germany. Upon completing his doctoral research thesis, he was awarded the "doctor medicinae" with magna cum laude. He completed a residency in Internal Medicine and a Hematology and Oncology fellowship at the University of Regensburg, Germany, and became Bone Marrow Transplant and Hematologic Malignancies Attending at the University of Regensburg. In 2009, he was awarded the "Habilitation", the highest academic qualification a scholar can achieve by own pursuit in Germany.

After moving to the United States, he was a faculty member at the Louisiana State University in Shreveport and at the University of Utah. He was the director of the bone marrow transplant program at LSUHSC Shreveport and director of the Utah Blood and Marrow Transplant program at the Huntsman Cancer Institute/University of Utah before moving to Kentucky.

He is a member of ASH, ASCO, ASBMT, AACR, the author of more than forty articles, books, and book chapters and is strongly involved in clinical trials.

Dr. Hildebrandt focuses on patients with cancers of the blood and lymph system, patients before and after blood or marrow stem cell transplantation, and on patients suffering from acute and chronic graft versus host disease.

Back to top

Jacob Hodskins, MD

Medical Oncologist
Owensboro Health Medical Group
Owensboro, Kentucky

Jacob S. Hodskins, MD, MS received his medical and graduate degrees from the University of Kentucky. He completed his residency with the University of Kentucky Department of Internal Medicine and a fellowship with the Department of Medical Oncology, Hematology and Bone Marrow Transplant at the University of Kentucky Markey Cancer Center. He currently practices in Owensboro, KY and is certified with the American Board of Internal Medicine in Internal Medicine, Hematology and Medical Oncology.

Back to top

Joseph Kim, MD

Chief of Surgery
Division of Surgical Oncology
University of Kentucky
College of Medicine
Lexington, Kentucky

Dr. Joseph Kim, MD is the chief of surgical oncology at University of Kentucky Markey Cancer Center. Dr. Kim earned his medical degree from the Loyola University Chicago Stritch School of Medicine. He then completed a residency in general surgery at the University of Cincinnati College of Medicine.

Dr. Kim completed a clinical and research fellowship in surgical oncology at the John Wayne Cancer Institute in Santa Monica, California. Additionally, Dr. Kim’s experience includes surgical oncology leadership roles at City of Hope in Duarte, California, and the State University of New York at Stony Brook, where he specialized in gastrointestinal cancers.

His clinical interests include the surgical treatment of hepatobiliary, gastric and pancreatic cancers. Dr. Kim performs hyperthermic intraperitoneal chemotherapy (HIPEC), an innovative procedure that delivers chemotherapy to the abdomen during surgery. He has performed more than 100 complex robotic GI procedures and has more than 15 years of experience with HIPEC procedures.

Dr. Kim is board certified in surgical oncology and specializes in the treatment of hepatobiliary and gastrointestinal cancers. He is a member of the surgical oncology team at the UK Markey Cancer Center dedicated to multidisciplinary evaluation and treatment.

As a scientist, Dr. Kim is currently conducting research aimed at characterizing the role of chemokine receptors in GI cancers and, ultimately, identifying novel therapeutic agents to prolong the survival of patients with these cancers.

Back to top

Charles Kunos, MD, PhD

Medical Officer
Investigational Drug Branch
Cancer Therapy Evaluation Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
Rockville, Maryland

Charles Kunos, MD, PhD, is a Medical Officer in the Investigational Drug Branch (IDB) of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis (DCTD) at the NCI and oversees adult and pediatric investigational therapeutics alone or in combination with radiation therapy. He received his medical and doctorate degrees from Case Western Reserve University School of Medicine in Cleveland, Ohio. He undertook radiation oncology training at the NCI-designated Case Comprehensive Cancer Center at University Hospitals of Cleveland. He then became the Clinical Director of the Gynecologic, Pediatric, and Musculoskeletal radiation therapy at University Hospitals of Cleveland. During his tenure, he developed skills in conventional radiotherapy, gynecologic brachytherapy, helical tomotherapy, gamma knife radiosurgery, and cyberknife stereotactic body radiosurgery. During this same time, he ran a radiobiology laboratory focused on the science of ribonucleotide reductase and its pharmacological inhibition by triapine using uterine cervix cancer preclinical models. He was the principal investigator for the NCI-sponsored phase I and II clinical trials of triapine radiochemotherapy for women with advanced stage uterine cervix cancer, which demonstrated very high overall response rates and progression-free survival. He was formerly the NCI Gynecologic Oncology Group’s liaison for Radiation Medicine, serving on multiple committees and task forces as well as serving as a Phase I co-chair of the Developmental Therapeutics Committee between 2012 and 2015.

Dr. Kunos joined NCI in 2016. He provides scientific review, develops and implements clinical trials, and monitors adverse events for a diverse drug portfolio involving experimental therapeutic agents that manipulate DNA damage responses by themselves or in combination with radiation therapy. He led NCI’s team that was granted Food & Drug Administration Orphan Drug Designation and Fast Track Designation for triapine in combination with cisplatin-radiation therapy for treatment of women with advanced stage uterine cervix cancer. He received a 2018 NCI Director’s Award for leading a team that improved uterine cervix cancer patient clinical trial access within Puerto Rico’s NCI Community Oncology Research Program (NCORP). He currently directs CTEP’s IDB Fellow and Early Career Investigator Externship Program and its educational efforts to improve written communication in CTEP’s Letters of Intent (LOIs). He also interacts with other NCI branches/programs as well as with other Federal Agencies to leverage resources in a first-ever CTEP clinical development program for radiopharmaceuticals.

Back to top

Amber Lawson, PharmD, BCOP

Pharmacy Clinical Coordinator - Oncology
Hematology/BMT Clinical Pharmacy Specialist
College of Pharmacy
University of Kentucky
Lexington, KY

Dr. Lawson completed her Doctor of Pharmacy degree at the University of Kentucky College of Pharmacy in 2002 and went on to complete an Oncology Pharmacy Residency in 2005 at Lucille Parker Markey Cancer Center at UK HealthCare in Lexington, Kentucky. She became a Board-Certified Oncology Pharmacist in 2006 and is an active member of the Hematology/Oncology Pharmacy Association and the American Society of Blood and Marrow Transplantation. She is currently the Clinical Coordinator for Hematology/Oncology Pharmacy Services at UK HealthCare and also serves as an adjunct assistant professor at the UK College of Pharmacy in Lexington, Kentucky.

Back to top

Rachel Miller, MD

Associate Professor
Obstetrics and Gynecology
University of Kentucky College of Medicine
Lexington, Kentucky

My name is Rachel Ware Miller; I received my medical degree from the University of Kentucky, College of Medicine. I then completed a fellowship at the University of Kentucky.

I am board certified by the American Board of Obstetrics and Gynecology in Obstetrics and Gynecology and Gynecologic Oncology.

I'm a gynecological oncologist, which means that I did specialized training after an OB-GYN residency to focus on cancers of the female reproductive tract. These include uterine, cervical, vulvar, vaginal and ovarian cancers. I love being able to practice medicine in the state where I grew up. After returning from my residency at Dartmouth, I realized how well I relate to people here in Central Kentucky. I grew up around these people, they're who I know.

I place a lot of importance on making the patient and their family feel comfortable. I really enjoy hearing the variety of replies that I get from patients when I ask how they spend their day-to-day and just hearing about the unique aspects of their lives. I see patients here locally as well as from rural parts of the state, and I think that's one of the things that I enjoy most. I see patients of all ages who are from a variety of backgrounds, education levels and social circumstances, and I really enjoy that aspect.

Back to top

Rachael Morgan, PharmD BCOP

Hematology/Oncology Clinical Pharmacist
Markey Cancer Center
UK Healthcare
Lexington, Kentucky

Dr. Morgan received her Doctor of Pharmacy degree from the University of Kentucky. She then completed a PGY1 pharmacy practice residency at Indiana University Health in Indianapolis and a PGY2 specialty residency in hematology/oncology at the University of Kentucky Medical Center.

Dr. Morgan provides comprehensive pharmaceutical care to patients at UK’s Markey Cancer Center, primarily practicing in the Multidisciplinary Clinic and on the inpatient medicine service dedicated to the care of oncology patients. Teaching activities include precepting students and residents on ambulatory oncology rotations and the inpatient medical oncology service, and participating in the oncology therapeutics curriculum at the UK College of Pharmacy. Her research interests include brain tumors, immunotherapy, patient outcomes and opioid stewardship.

Back to top

Brooke Phillips, MD

Medical Oncologist
St. Elizabeth Healthcare
Edgewood, Kentucky

Dr. Brooke Phillips is an oncologist in Covington, Kentucky and is affiliated with multiple hospitals in the area, including Presence St. Joseph Medical Center and Silver Cross Hospital. She received her medical degree from University of Kentucky College of Medicine.

Back to top

Reshma Ramlal, MD

Assistant Professor
Division of Hematology/BMT
University of Kentucky
Lexington, Kentucky

Dr. Reshma Ramlal is hematologist in Lexington, KY and is affiliated with University of Kentucky Albert B. Chandler Hospital. She received her medical degree from the University of the West Indies , Faculty of Medical Science, Port of Spain and received her residency training at the University of Florida Health Science Center in Jacksonville, FL. She received her hematology/oncology fellowship training at St. Louis University Hospital and stem cell transplantation training at the University of Texas, MD Anderson Cancer Center in Houston, TX. She has been in practice for 8 years.

Back to top

Hayder Saeed, MD

Assistant Professor
Hematology and Medical Oncology
University of Kentucky
Lexington Kentucky

Dr. Hayder Saeed is a medical oncologist in Lexington, Kentucky and is affiliated with University of Kentucky Albert B. Chandler Hospital. He received his medical degree from University of Baghdad College of Medicine and has been in practice between 6-10 years.

Back to top

Eytan Stein, MD

Hematologic Oncologist
Memorial Sloan Kettering Cancer Center
New York, New York

Back to top

Rachel Stewart, DO, PhD

Assistant Professor
Pathology and Laboratory Medicine
University of Kentucky
College of Medicine
Lexington, Kentucky

Rachel L. Stewart, DO, PhD, is an Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of Kentucky. She also serves as Scientific Associate Director for the Biospecimen Procurement and Translational Pathology Shared Resource Facility of the Markey Cancer Center. She received her medical degree from Touro University and completed residency training and her PhD at the University of Kentucky. Dr. Stewart then completed fellowship at the University of Utah in Molecular Genetic Pathology. She is board certified in Anatomic and Clinical Pathology and Molecular Genetic Pathology.

Back to top

John Villano, MD, PhD

Director of Clinical Neuro-Oncology
Professor, Depts. of Medicine, Neurosurgery, and Neurology
University of Kentucky
Lexington, Kentucky

Dr. John Villano specializes in the treatment of brain cancers. He will advance UK's Clinical Neuro-Oncology Research Program, serving as its director. Dr. Villano served as the director of medical Neuro-Oncology at the University of Illinois Medical Center. He earned an MD and PhD at the University of Texas Southwestern Medical School at Dallas and trained in neurology at the University of Michigan. He also completed a fellowship in hematology/oncology at the University of Chicago. Dr. Villano is a former American Society of Clinical Oncology track leader for CNS tumors. Currently, he is on the board of the Central Brain Tumor Registry US. He is also a member of the Neuro-Oncology Committee in the cooperative group ALLIANCE and a Society of Neuro-Oncology committee member.

Back to top

Peng Wang, MD

Assistant Professor of Medicine
Division of Medical Oncology
Markey Cancer Center
Department of Internal Medicine
University of Kentucky
Lexington, Kentucky

Dr. Peng Wang received his MD/PhD degree at the TongJi Medical University, China. He then went to the University of Nebraska Medical Center and Vanderbilt University to study lymphoma genesis as a postdoc fellow. After he finished his Internal Medicine residency training at the Maricopa Medical Center, AZ and Hematology/Oncology fellowship training at the University of Pittsburgh Medical Center, PA, he joined the Division of Medical Oncology at the University of Kentucky as an assistant professor in August 2013. Dr. Wang is pursuing clinical and translational studies in genitourinary malignancies. His interests also include experimental cancer therapeutics.

Back to top

Shulin Zhang, MD, PhD, FACMG, FCCMG

Professor of Pathology and Medicine
University of Kentucky
College of Medicine
Lexington, Kentucky

Back to top